Rare Disease Report

Millennial Gaucher Patient Prefers Oral Medication to ERT

AUGUST 18, 2016
Andrew Black
In our RDR exclusive interview with Lauren Edwards, a Gaucher disease patient and adovcate, she described the advantages of switching from standard enzyme replacement therapy (ERT) infusions, to taking Genzyme's Cerdelga and how beneficial it was to her busy student lifestyle.



Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.